Audited annual filings, TTM ratios and consensus forward estimates
Wall Street price targets and rating actions
Revenue disaggregation per 10-K filing
Annual filings (FY) with consensus forward estimates (hatched)
Current price $0.0002
Latest analyst grade actions
| Date | Firm | Action | Previous | New grade |
|---|---|---|---|---|
| Aug 8, 25 | D. Boral Capital | maintain | Buy | Buy |
| Apr 1, 25 | D. Boral Capital | maintain | Buy | Buy |
| Jan 17, 25 | D. Boral Capital | maintain | Buy | Buy |
| Jan 13, 25 | D. Boral Capital | maintain | Buy | Buy |
| Dec 16, 24 | HC Wainwright & Co. | downgrade | Buy | Neutral |
| Dec 12, 24 | Baird | downgrade | Outperform | Neutral |
| Dec 12, 24 | D. Boral Capital | maintain | Buy | Buy |
| Dec 11, 24 | Evercore ISI Group | downgrade | Outperform | In Line |
| Dec 10, 24 | BTIG | downgrade | Buy | Neutral |
1255 daily bars · split adjusted
Daily · Wilder smoothing
Classic floor pivots from 2026-10-23
Computed from daily OHLCV bars
| Indicator | Value | Type | Action |
|---|---|---|---|
| RSI (14) | 47.45 | Oscillator | Neutral |
| Stochastic %K (14, 3, 3) | 0.00 | Oscillator | Buy |
| Williams %R (14) | -100.00 | Oscillator | Buy |
| MACD (12, 26, 9) | -0.00 (Hist -0.00) | Oscillator | Strong Sell |
| Average Directional Index (14) | 44.06 (+DI 47.3 / -DI 3.2) | Trend | Strong Buy |
| EMA 20 | 0.00 | MA | Strong Sell |
| SMA 20 | 0.00 | MA | Strong Sell |
| EMA 50 | 0.00 | MA | Strong Sell |
| SMA 50 | 0.00 | MA | Strong Sell |
| SMA 200 | 0.02 | MA | Strong Sell |
SEC EDGAR filings · last 12 months
| Form | Filed | Accepted | Document |
|---|---|---|---|
| 15-12G | Dec 29, 2025 | 2025-12-29 07:52:03 | View |
| EFFECT | Dec 16, 2025 | 2025-12-17 00:15:34 | View |
| EFFECT | Dec 16, 2025 | 2025-12-17 00:15:18 | View |
| EFFECT | Dec 16, 2025 | 2025-12-17 00:15:09 | View |
| EFFECT | Dec 16, 2025 | 2025-12-17 00:15:04 | View |
| S-8 POS | Dec 15, 2025 | 2025-12-15 16:15:07 | View |
| S-8 POS | Dec 15, 2025 | 2025-12-15 16:14:48 | View |
| S-8 POS | Dec 15, 2025 | 2025-12-15 16:14:35 | View |
| S-8 POS | Dec 15, 2025 | 2025-12-15 16:14:20 | View |
| S-8 POS | Dec 15, 2025 | 2025-12-15 16:14:06 | View |
Proxy statement (DEF 14A) disclosures
FY2024 · 10-K disclosure
TTM vs. 5-year historical average (annual ratios)
| Metric | CARM | Historical (5Y) / ref | Status |
|---|---|---|---|
| P/E ratio (TTM) | 0.0x | -1832.4x · sector 20.7x | Discount |
| Forward P/E (FY25E) | -0.0x | EPS est. -0.69 | Discount |
| Price / Book | -0.0x | -77.6x | Discount |
| Price / Sales | 0.0x | 280.3x | Discount |
| EV / EBITDA | -0.1x | -131.3x | Discount |
| Return on equity | -149.1% | — | Weak |
| Gross margin | 99.2% | -60.2% | Below hist. |
| Debt / Equity | -0.88 | -0.04 | Conservative |
| Piotroski / Altman Z | 3/9 | Z -45.90 | Distress |
Stock news · updated daily
Reported EPS vs. consensus estimate
| Report date | EPS est. | EPS actual | Surprise | Revenue |
|---|---|---|---|---|
| Nov 12, 2025 | — | 1.07 | — | — |
| Aug 7, 2025 | -0.12 | -0.12 | Beat 0.0% | — |
Discounted cash flow model
| May 13, 2025 | -0.12 | -0.22 | Miss -83.3% | $3.73M |
| Mar 31, 2025 | -0.16 | -0.42 | Miss -162.5% | $3.65M |
| Nov 7, 2024 | -0.31 | -0.31 | Beat 0.0% | $3.38M |
Free float vs. closely held shares
13F institutional holdings are not available in the current data plan.
SEC Form 4 filings
| Date | Insider | Role | Type | Shares @ price | Value |
|---|---|---|---|---|---|
| Oct 7, 25 | Klichinsky Michael | officer: Chief Scientific Officer | M-Exempt | 56,982 @ $0.11 | $6.27K |
| Oct 7, 25 | Klichinsky Michael | officer: Chief Scientific Officer | S-Sale | 56,982 @ $0.2542 | $14.48K |
| Oct 7, 25 | Klichinsky Michael | officer: Chief Scientific Officer | M-Exempt | 56,982 @ $0.11 | $6.27K |
| Oct 1, 25 | Klichinsky Michael | officer: Chief Scientific Officer | S-Sale | 165,000 @ $0.257 | $42.41K |
| Oct 2, 25 | Klichinsky Michael | officer: Chief Scientific Officer | S-Sale | 200,000 @ $0.2543 | $50.86K |
| Oct 3, 25 | Klichinsky Michael | officer: Chief Scientific Officer | S-Sale | 119,347 @ $0.2604 | $31.08K |
| Jan 28, 25 | Klichinsky Michael | officer: Chief Scientific Officer | A-Award | 221,000 @ $0.50 | $110.5K |
| Jan 28, 25 | Kelly Steven | director, officer: President and CEO | A-Award | 500,000 @ $0.50 | $250.0K |